Major concerns were raised about the quality of early batches of Pfizer 's coronavirus vaccine, leaked documents from the EU's medical regulato r have revealed. Scientists charged with checking the chemicals sent to the bloc for approval last year found doses were of a lower standard than the US drugmaker had promised. In an email dated November 23, a senior European Medicines Agency official warned of a 'significant difference' in ...